BioSpace News Archive

Press Releases

Cybin Highlights 2024 Accomplishments and Upcoming Milestones for 2025

January 13, 2025
·
9 min read
Press Releases

Verastem Oncology Announces Debt Refinancing with Oberland Capital and Strategic Commercialization Partnership with IQVIA to Support Potential Launch in Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer in Mid-2025

January 13, 2025
·
14 min read
Press Releases

ORIC® Pharmaceuticals Provides Early Phase 1b Combination Data for ORIC-944, Operational Highlights for 2024, and Anticipated Upcoming Milestones

January 13, 2025
·
10 min read
Press Releases

Ardelyx Provides Update on Increasing Commercial Momentum and 2025 Strategic Priorities

January 13, 2025
·
9 min read
Press Releases

Ashvattha Therapeutics Announces $50 Million Financing Extension and Interim Phase 2 Ophthalmology Trial Results

January 13, 2025
·
3 min read
Press Releases

Candel Therapeutics Provides Corporate Update and Highlights Strong Pipeline Momentum and Key Value Drivers for 2025

January 13, 2025
·
16 min read
Press Releases

Protara Highlights Recent Updates and Anticipated 2025 Milestones

January 13, 2025
·
8 min read
Press Releases

Transpire Bio Announces Progress in Clinical Development with Initiation of a New Human Subject Study for Asthma and COPD Inhaled Drug Program

January 13, 2025
·
1 min read
Press Releases

Werewolf Therapeutics Provides Business Update and Highlights 2025 Strategic Outlook

January 13, 2025
·
8 min read
Press Releases

ITM and Ariceum Therapeutics Enter Into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225

January 13, 2025
·
5 min read